Alzheimers Dementia:白天小憩,和痴呆有何关系?

2022-03-21 网络 网络

白天过度的午睡和阿尔茨海默氏症可能具有双向关系,或有共同的病理生理机制。

最近提出的一个机制是,由于与tau缠结(AD的病理特征之一)相关的促醒神经元和神经递质损失导致唤醒不足,从而造成睡眠-觉醒障碍和更高的日间午睡倾向。 反过来说,白天的过度困倦,可能是导致更长时间和频繁午睡的原因,也与认知能力下降或AD病理积累的速度有关。

然而,在之前的研究中,关于白天小睡对认知的影响仍然存在矛盾的结果。虽然一些研究显示小睡对急性认知表现、情绪和警觉性有好处,尤其是在年轻的成年人中,但更多的小睡也与长期的不良结果有关,包括认知能力差。 例如,一些横断面研究报告了自我报告的过度午睡与认知功能恶化之间的关联;最近的一项纵向研究也显示,在老年男性中,较长的午睡时间与较快的认知衰退之间存在关联。然而,其他研究也证明了相反的情况--自我报告的午睡与较低的认知障碍几率有关。

然而,所有先前的研究都只对每个参与者进行了一次午睡评估。目前仍不清楚白天的午睡是如何随着年龄的增长,特别是认知的衰老而演变的。此外,这些研究大多采用主观的午睡评估,可能并不可靠,特别是在老年人的认知状态下。要了解白天的午睡和AD之间的复杂联系,需要对客观午睡进行纵向评估。

藉此, 哈佛大学的Peng Li等人, 探究了:
(1)随着年龄的增长,参与者的午睡时间更长和/或更频繁,这种纵向变化随着参与者从无认知障碍到轻度认知障碍(MCI)的进展而加剧,并在诊断为阿尔茨海默氏痴呆后进一步加速;

(2)白天客观午睡时间过长(即更长和/或更频繁)的参与者患阿尔茨海默氏痴呆的风险增加。

他们发现:随着年龄的增长,老年人倾向于更长时间和更频繁地午睡,而阿尔茨海默氏症的进展加速了这种变化,使每年的午睡时间/频率增加了一倍以上。

更长和更频繁的日间小睡与阿尔茨海默氏痴呆症的高风险有关。

有趣的是,更多过度(更长或更频繁)的日间小睡与一年后的认知能力更差相关,反之,更差的认知能力与一年后更多的过度小睡相关。


该研究的重要意义在于发现了:白天过度的午睡和阿尔茨海默氏症可能具有双向关系,或有共同的病理生理机制。


原文出处:
Li P, Gao L, Yu L, et al. Daytime napping and Alzheimer’s dementia: A potential bidirectional relationship. Alzheimer’s & Dementia. Published online March 17, 2022:alz.12636. doi:10.1002/alz.12636

评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1718136, encodeId=249e1e1813614, content=<a href='/topic/show?id=8f0658433a' target=_blank style='color:#2F92EE;'>#dementia#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5843, encryptionId=8f0658433a, topicName=dementia)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=307e32501717, createdName=linlin2323, createdTime=Tue Feb 28 09:26:17 CST 2023, time=2023-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878495, encodeId=3c3d18e84959e, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=199, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Mon Jan 16 05:26:17 CST 2023, time=2023-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779837, encodeId=18ef1e79837bc, content=<a href='/topic/show?id=51b4238909' target=_blank style='color:#2F92EE;'>#alzheimers#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2389, encryptionId=51b4238909, topicName=alzheimers)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Thu Jul 14 13:26:17 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338555, encodeId=f2021338555b9, content=<a href='/topic/show?id=767711566a9' target=_blank style='color:#2F92EE;'>#MERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11566, encryptionId=767711566a9, topicName=MERS)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/71tKRib0PibveVjnEa7tPLMaCzoKicFlKSEOzRTGf4wNvDV54kJyNx1ott1D5Xp5gRu7IwUia77oN0YFdffvQMu6Ug/132, createdBy=9e302500146, createdName=ms49895894946433513521, createdTime=Wed Mar 23 20:26:17 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1246691, encodeId=09e5124669149, content=老年性痴呆,未来还是希望借助神经电生理吧,也许更为有效!, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuro.Dr, createdTime=Tue Mar 22 08:26:17 CST 2022, time=2022-03-22, status=1, ipAttribution=)]
    2023-02-28 linlin2323

    #dementia#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1718136, encodeId=249e1e1813614, content=<a href='/topic/show?id=8f0658433a' target=_blank style='color:#2F92EE;'>#dementia#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5843, encryptionId=8f0658433a, topicName=dementia)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=307e32501717, createdName=linlin2323, createdTime=Tue Feb 28 09:26:17 CST 2023, time=2023-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878495, encodeId=3c3d18e84959e, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=199, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Mon Jan 16 05:26:17 CST 2023, time=2023-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779837, encodeId=18ef1e79837bc, content=<a href='/topic/show?id=51b4238909' target=_blank style='color:#2F92EE;'>#alzheimers#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2389, encryptionId=51b4238909, topicName=alzheimers)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Thu Jul 14 13:26:17 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338555, encodeId=f2021338555b9, content=<a href='/topic/show?id=767711566a9' target=_blank style='color:#2F92EE;'>#MERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11566, encryptionId=767711566a9, topicName=MERS)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/71tKRib0PibveVjnEa7tPLMaCzoKicFlKSEOzRTGf4wNvDV54kJyNx1ott1D5Xp5gRu7IwUia77oN0YFdffvQMu6Ug/132, createdBy=9e302500146, createdName=ms49895894946433513521, createdTime=Wed Mar 23 20:26:17 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1246691, encodeId=09e5124669149, content=老年性痴呆,未来还是希望借助神经电生理吧,也许更为有效!, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuro.Dr, createdTime=Tue Mar 22 08:26:17 CST 2022, time=2022-03-22, status=1, ipAttribution=)]
    2023-01-16 anminleiryan

    #ERS#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1718136, encodeId=249e1e1813614, content=<a href='/topic/show?id=8f0658433a' target=_blank style='color:#2F92EE;'>#dementia#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5843, encryptionId=8f0658433a, topicName=dementia)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=307e32501717, createdName=linlin2323, createdTime=Tue Feb 28 09:26:17 CST 2023, time=2023-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878495, encodeId=3c3d18e84959e, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=199, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Mon Jan 16 05:26:17 CST 2023, time=2023-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779837, encodeId=18ef1e79837bc, content=<a href='/topic/show?id=51b4238909' target=_blank style='color:#2F92EE;'>#alzheimers#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2389, encryptionId=51b4238909, topicName=alzheimers)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Thu Jul 14 13:26:17 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338555, encodeId=f2021338555b9, content=<a href='/topic/show?id=767711566a9' target=_blank style='color:#2F92EE;'>#MERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11566, encryptionId=767711566a9, topicName=MERS)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/71tKRib0PibveVjnEa7tPLMaCzoKicFlKSEOzRTGf4wNvDV54kJyNx1ott1D5Xp5gRu7IwUia77oN0YFdffvQMu6Ug/132, createdBy=9e302500146, createdName=ms49895894946433513521, createdTime=Wed Mar 23 20:26:17 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1246691, encodeId=09e5124669149, content=老年性痴呆,未来还是希望借助神经电生理吧,也许更为有效!, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuro.Dr, createdTime=Tue Mar 22 08:26:17 CST 2022, time=2022-03-22, status=1, ipAttribution=)]
    2022-07-14 dingxiaobo
  4. [GetPortalCommentsPageByObjectIdResponse(id=1718136, encodeId=249e1e1813614, content=<a href='/topic/show?id=8f0658433a' target=_blank style='color:#2F92EE;'>#dementia#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5843, encryptionId=8f0658433a, topicName=dementia)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=307e32501717, createdName=linlin2323, createdTime=Tue Feb 28 09:26:17 CST 2023, time=2023-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878495, encodeId=3c3d18e84959e, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=199, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Mon Jan 16 05:26:17 CST 2023, time=2023-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779837, encodeId=18ef1e79837bc, content=<a href='/topic/show?id=51b4238909' target=_blank style='color:#2F92EE;'>#alzheimers#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2389, encryptionId=51b4238909, topicName=alzheimers)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Thu Jul 14 13:26:17 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338555, encodeId=f2021338555b9, content=<a href='/topic/show?id=767711566a9' target=_blank style='color:#2F92EE;'>#MERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11566, encryptionId=767711566a9, topicName=MERS)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/71tKRib0PibveVjnEa7tPLMaCzoKicFlKSEOzRTGf4wNvDV54kJyNx1ott1D5Xp5gRu7IwUia77oN0YFdffvQMu6Ug/132, createdBy=9e302500146, createdName=ms49895894946433513521, createdTime=Wed Mar 23 20:26:17 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1246691, encodeId=09e5124669149, content=老年性痴呆,未来还是希望借助神经电生理吧,也许更为有效!, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuro.Dr, createdTime=Tue Mar 22 08:26:17 CST 2022, time=2022-03-22, status=1, ipAttribution=)]
    2022-03-23 ms49895894946433513521

    #MERS#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1718136, encodeId=249e1e1813614, content=<a href='/topic/show?id=8f0658433a' target=_blank style='color:#2F92EE;'>#dementia#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=214, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5843, encryptionId=8f0658433a, topicName=dementia)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=307e32501717, createdName=linlin2323, createdTime=Tue Feb 28 09:26:17 CST 2023, time=2023-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878495, encodeId=3c3d18e84959e, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=199, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Mon Jan 16 05:26:17 CST 2023, time=2023-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1779837, encodeId=18ef1e79837bc, content=<a href='/topic/show?id=51b4238909' target=_blank style='color:#2F92EE;'>#alzheimers#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2389, encryptionId=51b4238909, topicName=alzheimers)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=930e243, createdName=dingxiaobo, createdTime=Thu Jul 14 13:26:17 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338555, encodeId=f2021338555b9, content=<a href='/topic/show?id=767711566a9' target=_blank style='color:#2F92EE;'>#MERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11566, encryptionId=767711566a9, topicName=MERS)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/71tKRib0PibveVjnEa7tPLMaCzoKicFlKSEOzRTGf4wNvDV54kJyNx1ott1D5Xp5gRu7IwUia77oN0YFdffvQMu6Ug/132, createdBy=9e302500146, createdName=ms49895894946433513521, createdTime=Wed Mar 23 20:26:17 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1246691, encodeId=09e5124669149, content=老年性痴呆,未来还是希望借助神经电生理吧,也许更为有效!, beContent=null, objectType=article, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=neuro.Dr, createdTime=Tue Mar 22 08:26:17 CST 2022, time=2022-03-22, status=1, ipAttribution=)]
    2022-03-22 neuro.Dr

    老年性痴呆,未来还是希望借助神经电生理吧,也许更为有效!

    0

相关资讯

Alzheimer Dementia:C反应蛋白,和痴呆风险息息相关

基线的低血浆CRP水平与普通人群中AD的高风险有关

Alzheimers Dementia:轻度行为障碍,可预示痴呆进展

这些发现支持MBI的生物学基础,强调了晚年行为变化在痴呆症检测和预后中的重要性。

JAMA子刊:超5000万人数据提示,新冠流行期间痴呆患者死亡率在攀升!

COVID-19的流行可能与患有ADRD的老年人的超额死亡率有关。

Movement Disorder:新药Mevidalen治疗路易体痴呆,疗效如何

Mevidalen利用一种新的作用机制,在标准护理的基础上改善与LBD相关的运动症状

Aging:老年痴呆患者肠道微生物菌群分析

AD谱系的患者表现出GM丰度的改变,这在不同的国家和临床阶段有不同的介导作用。

注意了——绝经期提前到,老年痴呆症风险增加三分之一!那么,几岁是个坎?

痴呆症是一种复杂的疾病,主要表现为认知能力下降,由遗传和环境因素共同影响。目前,

拓展阅读

JAMA子刊:首次尸检证据,MIND饮食或通过减少海马硬化降低老年痴呆风险

本研究首次证实,在社区老年人群中,MIND饮食依从性与HS、HS合并LATE-NC发生率降低及海马神经元丢失减少显著相关。

Annals of neurology:阿尔茨海默病的“时间地图”:血浆生物标志物如何预示大脑正在改变?

这项研究所搭建的“血液生物标志物时钟”,或许将成为AD研究的一个关键转折点。

JAMA子刊:治疗听力损失能延缓老年痴呆症发生吗?

治疗听力损失可能会延缓大量老年人的痴呆。针对临床显著听力计测量的听力损失的公共卫生干预措施可能对痴呆预防具有广泛益处。

Alzheimer’s & Dementia:大规模模拟试验揭示,他汀类药物对不同社会人口学群体痴呆患病风险无显著差异

他汀启动与未启动组的ADRD风险无显著差异(全队列HR=0.99),且年龄、性别、种族、教育、收入等社会人口学因素均未显著修饰这一关联(所有亚组p>0.05)。

JNNP:阿尔茨海默病患者的精神行为症状,竟能通过血液提前预测?

血浆蛋白标志物可以作为一种便捷、无创的监测手段,帮助医生更早识别高风险患者,甚至针对特定症状(如攻击行为或淡漠)制定个性化治疗方案。

JNNP:阿尔茨海默病的隐秘轨迹,大脑结构变化竟始于中年?

纵向追踪(即对同一人群多次脑扫描)仍是未来的金标准。

2022 欧洲共识:MCI和轻度痴呆初级阶段的诊断和治疗

意大利阿尔兹海默病专家组 · 2022-10-09

适合痴呆症患者的急救护理:老年急救护理应用研究网络范围审查和共识会议的结果

急性期后和长期护理学会(AMDA,The Society for Post-Acute and Long-Term Care Medicine) · 2022-08-01

痴呆及阿尔茨海默病进展要点简析

四川大学华西医院 · 2022-07-26